Carregant...
How I manage frontline transplant-eligible multiple myeloma in Italy
The treatment of transplant-eligible multiple myeloma patients in Italy consists in an induction phase based on bortezomib plus thalidomide plus dexamethasone (VTd), followed by a single or tandem autologous stem cell transplantation (ASCT), followed by lenalidomide maintenance. This approach offers...
Guardat en:
| Publicat a: | Hematol Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
PAGEPress Publications, Pavia, Italy
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520856/ https://ncbi.nlm.nih.gov/pubmed/33042503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2020.8954 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|